The new B•R•A•H•M•S PCT direct point of care assay requires just one drop of blood for a reliable infection diagnosis and clinical decisions in the acute care setting within 20 minutes ...

The Lumipulse ® G B•R•A•H•M•S PCT Assay, when run on the LUMIPULSE ® G1200 immunoassay platform, and used in conjunction with other laboratory findings and clinical assessments ...

PCT is a sensitive and specific biomarker of systemic bacterial infection. Clinicians can now use B·R·A·H·M·S PCT to help assess the response of septic patients to treatment by comparing a ...

HENNIGSDORF, Germany--(BUSINESS WIRE)--For healthcare professionals facing the complexity of daily requirements in emergency situations, a new point-of-care test, Samsung IB B·R·A·H·M·S PCT ...

Fujirebio Diagnostics, Inc., has received U.S. Food and Drug Administration (FDA) clearance of the company’s Lumipulse® G B•R•A•H•M•S PCT Assay for testing on its LUMIPULSE® G1200 immunoassay platform ...